Cary Street Partners Investment Advisory’s AdvisorShares Pure US Cannabis ETF MSOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-350
Closed -$2.78K 1363
2023
Q3
$2.78K Hold
350
﹤0.01% 1605
2023
Q2
$1.94K Hold
350
﹤0.01% 1595
2023
Q1
$1.99K Hold
350
﹤0.01% 1499
2022
Q4
$2.45K Buy
+350
New +$3.6K ﹤0.01% 1476

Other funds holding MSOS

Cary Street Partners Investment Advisory's MSOS Position: Q4 2023 in Review

Cary Street Partners Investment Advisory sold out of AdvisorShares Pure US Cannabis ETF (MSOS) in Q4 2023, closing a stake of 350 shares — an estimated $2.78K sold.

Cary Street Partners Investment Advisory first reported a position in MSOS in Q4 2022 and held it in 4 quarters. The position peaked at $2.78K in Q3 2023. 171 funds tracked by Wall St. Rank hold MSOS as of Q4 2023.

  • Cary Street Partners Investment Advisory reported no remaining AdvisorShares Pure US Cannabis ETF position as of Q4 2023 after selling out during the quarter.
  • Cary Street Partners Investment Advisory sold 350 AdvisorShares Pure US Cannabis ETF shares in Q4 2023, an estimated $2.78K.
  • Cary Street Partners Investment Advisory first reported a position in AdvisorShares Pure US Cannabis ETF in Q4 2022 and held it in 4 quarters.
  • Cary Street Partners Investment Advisory's AdvisorShares Pure US Cannabis ETF position peaked at $2.78K in Q3 2023.
  • 171 funds tracked by Wall St. Rank held AdvisorShares Pure US Cannabis ETF as of Q4 2023.

Based on Cary Street Partners Investment Advisory's 13F filing for Q4 2023, filed 5 Feb 2024.